GlassScriptPhysician profile
Jillian Vaughan
NPI 1437758489
$6,205.34
in general payments reported to CMS, 2019-2025
17 companies · $2,043 in 2025
The $2,043 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $124 · 2022: $215 · 2023: $2,846 · 2024: $978 · 2025: $2,043.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,397 · Food and Beverage: $2,470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,396.92 |
| Food and Beverage | $2,469.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,087.24 | 2021-2025 | Intracept, General - Pain Management |
| Curonix LLC | $1,663.72 | 2022-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spinal Simplicity, LLC | $1,269.89 | 2023 | Ha Minuteman G3-R |
| Medtronic, INC. | $466.67 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Synchromedii |
| Saluda Medical Americas, INC. | $202.69 | 2024 | Evoke |
| Abbott Laboratories | $164.68 | 2025 | Eterna, Proclaim |
| Stimwave Technologies Incorporated | $95.56 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.39 | 2022-2024 | Relistor |
| Depuy Synthes Sales INC. | $40.96 | 2024-2025 | Orthovisc, Monovisc |
| Nalu Medical, INC. | $33.02 | 2023-2024 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $23.07 | 2025 | |
| Alnylam Pharmaceuticals INC. | $17.95 | 2023 | Amvuttra |
| Merz North America, INC. | $17.85 | 2025 | |
| Lilly USA, LLC | $17.24 | 2021 | |
| Bioventus LLC | $14.73 | 2025 | Gelsyn-3 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $14.66 | 2022 | |
| Spr Therapeutics, INC | $10.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Vaughan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.